Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2465]

Drug dismantles a metabolic barrier to anti-tumour immunity

Drug dismantles a metabolic barrier to anti-tumour immunity

New way to prevent duodenal cancer

New way to prevent duodenal cancer

NICE approves dual immunotherapy for the first line treatment of adult patients with mismatch repair deficient or microsatellite instability high unresectable or metastatic colorectal cancer approved in the UK

NICE approves dual immunotherapy for the first line treatment of adult patients with mismatch repair deficient or...

For colon cancer that no longer responds to treatment, a new drug combination offers hope

For colon cancer that no longer responds to treatment, a new drug combination offers hope

University effectively tests molecules capable of improving immunity or reducing inflammation of the tumour ecosyst

University effectively tests molecules capable of improving immunity or reducing inflammation of the tumour ecosyst

Walnut consumption curbs inflammation and colon cancer risk

Walnut consumption curbs inflammation and colon cancer risk

Liquid biopsy: A breakthrough technology in early cancer screening

Liquid biopsy: A breakthrough technology in early cancer screening

New insights into cancer biology: the dual role of FMRP in tumour progression and therapy resistance

New insights into cancer biology: the dual role of FMRP in tumour progression and therapy resistance

University uncovers early mutations and risk factors for stomach cancer, and develops a pre-cancer model for stomach cancer prevention

University uncovers early mutations and risk factors for stomach cancer, and develops a pre-cancer model for...

Exploring the mutational landscape of colorectal cancer

Exploring the mutational landscape of colorectal cancer

More from ecancer